GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annji Pharmaceutical Co Ltd (ROCO:7754) » Definitions » Research & Development

Annji Pharmaceutical Co (ROCO:7754) Research & Development : NT$321.49 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Annji Pharmaceutical Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Annji Pharmaceutical Co's Research & Development for the six months ended in Dec. 2024 was NT$146.88 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was NT$321.49 Mil.

Annji Pharmaceutical Co Research & Development Historical Data

The historical data trend for Annji Pharmaceutical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Annji Pharmaceutical Co Research & Development Chart

Annji Pharmaceutical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Research & Development
184.42 223.43 247.15 321.49

Annji Pharmaceutical Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24
Research & Development Get a 7-Day Free Trial - 115.15 132.00 174.61 146.88

Annji Pharmaceutical Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$321.49 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Annji Pharmaceutical Co  (ROCO:7754) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Annji Pharmaceutical Co Research & Development Related Terms

Thank you for viewing the detailed overview of Annji Pharmaceutical Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Annji Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annji Pharmaceutical Co Ltd (ROCO:7754) » Definitions » Research & Development
Comparable Companies
ROCO:6704 ROCO:6846 ROCO:1295 TPE:1762 ROCO:4168 ROCO:4130 ROCO:6676 ROCO:6872 TPE:3164 ROCO:7806 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Zhongxiao E. Raod, 16th Floor-6, No. 508, Sector 7, Nangang Distrist, Taipei, TWN, 115011
Website
https://www.ajpharm.com
Annji Pharmaceutical Co Ltd is an R&D based, clinical-stage new drug company dedicated to the development of first-in-class small molecules focusing on indications with highly unmet needs in the therapeutic areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy's disease, or SBMA (Spinal and bulbar muscular atrophy). Its pipeline products include AJ201, AJ302 and AJ303.

Annji Pharmaceutical Co Headlines

No Headlines